Shortening tuberculosis treatment has emerged as a promising strategy to improve adherence, reduce toxicity, and accelerate disease control. While newer regimens show encouraging efficacy, concerns remain regarding relapse rates, drug resistance, patient selection, and real-world implementation. This ongoing debate weighs clinical benefits against potential risks, emphasizing the need for robust evidence, careful monitoring, and context-specific application to ensure that shorter regimens deliver sustained outcomes without compromising long-term tuberculosis control. Gain detailed insights into shortening tuberculosis treatment from renowned pulmonologists Dr.
Vinod Kumar Viswananthan and Dr. Jai Kishan Karahyla in our exclusive webinar, organized in association with the Indian Chest Society on January 30 , 2026 , at 8:30 PM IST . Stay tuned! ##Disclaimer## The content provided on…
